Drugs / CKD-375
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04221360 | Jan → Mar 2020 | type 2 diabetes mellitus | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
| Phase 1 | NCT03848637 | Apr 2019 | type 2 diabetes mellitus | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKD-375 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04221360 ↗ |
| Route | Oral | “after oral administration of CKD-375 and D387 in healthy adults.” NCT03848637 ↗ |